{{Rsnum
|rsid=427576
|Chromosome=16
|position=73795371
|Orientation=plus
|GMAF=0.4793
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene=LOC101927998
|Gene_s=LOC101927998
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 19.5 | 54.9 | 25.7
| HCB | 21.9 | 51.8 | 26.3
| JPT | 20.4 | 53.1 | 26.5
| YRI | 21.1 | 53.7 | 25.2
| ASW | 17.5 | 59.6 | 22.8
| CHB | 21.9 | 51.8 | 26.3
| CHD | 22.9 | 50.5 | 26.6
| GIH | 11.0 | 49.0 | 40.0
| LWK | 22.9 | 51.4 | 25.7
| MEX | 25.9 | 46.6 | 27.6
| MKK | 30.8 | 41.0 | 28.2
| TSI | 30.4 | 52.9 | 16.7
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=C
  |Pval=4E-6
  |OR=2.62
  |ORtxt=[1.5-3.74] mg/dL decrease
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}